Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
5661
-
5662
Ab Initio Prediction of Proton Exchange Barriers for Alkanes at Brønsted Sites of Zeolite H‑MFI
Published 2018“…A change to the indirect proton exchange mechanism, in which a hydride ion is transferred between the alkane and a <i>tert</i>-butyl carbenium ion can be excluded, because we confirm previous findings that the barrier for dehydrogenation that would create a <i>tert</i>-butyl cation from <i>i</i>-butane is much too high, 188 and 132 kJ/mol for the intrinsic and apparent enthalpy barriers, respectively, at 500 K. …”
-
5663
-
5664
-
5665
-
5666
-
5667
Presentation 1_Loss-of-function mitochondrial DNA polymerase gamma variants cause vascular smooth muscle cells to secrete a diffusible mitogenic factor.pdf
Published 2025“…Live-cell imaging growth analyses again showed increased growth in A7r5 cells transfected with p.Tyr955Cys but a decreased growth with p.Arg1138Cys, while p.Tyr955Cys increased growth of HeLa cells. …”
-
5668
-
5669
-
5670
-
5671
SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue
Published 2018“…<div><p>SERINC5 is a host restriction factor that impairs infectivity of HIV-1 and other primate lentiviruses and is counteracted by the viral accessory protein Nef. …”
-
5672
Demographic characteristics of participants.
Published 2025“…Results showed that a minority of participants (9.5%) were free of comorbidities. …”
-
5673
Comorbidities patterns among participants.
Published 2025“…Results showed that a minority of participants (9.5%) were free of comorbidities. …”
-
5674
-
5675
-
5676
-
5677
-
5678
-
5679
-
5680